STAHIST AD
NDC 58407-625, CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE, tablet, from Magna Pharmaceuticals, Inc..
- Product NDC
- 58407-625
- Status
- Listed
- Labeler
- Magna Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58407-625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORCYCLIZINE HYDROCHLORIDE25 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58407-625-01 | 58407062501 | 1 TABLET in 1 BLISTER PACK (58407-625-01) |
| 58407-625-06 | 58407062506 | 6 BLISTER PACK in 1 BOX (58407-625-06) / 1 TABLET in 1 BLISTER PACK (58407-625-01) |
| 58407-625-30 | 58407062530 | 1 BOTTLE in 1 BOX (58407-625-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58407-625 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58407-625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58407-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.